©2024 Stanford Medicine
Clinical Trials Contact
About this Clinical Trial
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery
Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery